Optibrium is dedicated to providing software to guide decisions involving complex, uncertain data in an intuitive way. Our primary product, StarDrop, is focussed on the drug discovery industry, helping scientists to guide decisions in the design and selection of potential drug molecules.
Optibrium was founded in 2009 as a spin-out of BioFocus DPI (formerly Inpharmatica). The founding group was responsible for the development of StarDrop from 2003 and, prior to this, research and development of related technologies since 1994.
Based in Cambridge, UK, Optibrium has a global customer base ranging from top-10 pharmaceutical companies to small biotechs and academic groups.
Specialties
drug discovery software, decision analysis, predictive ADME, in silico
Optibrium Ltd. Activity on LinkedIn
-
Optibrium Ltd. Our review article "Multi-Parameter Optimization: Identifying high quality compounds with a balance of properties" appeared in Curr. Pharm. Des. 18(9) p. 1292 (2012). Download a preprint from the Optibrium on-line community. -
Optibrium Ltd. Optibrium is attending Molecular Med Tri-Con in San Francisco next week. Visit us at booth 501 to learn about the latest StarDrop developments and pick up a free copy of the new version of StarVue; now available on the Mac.
